CBE ID
0612
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description
The percentage of patients taking warfarin who had PT/INR monitoring
Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
1.8 Level of Analysis
1.9 Care Setting
1.20 Types of Data Sources
Numerator
1.14 Numerator
Patients who had PT/INR monitoring
Denominator
1.15 Denominator
Patients with a current fill for warfarin
Exclusions
Exclusions
SPECIFIC EXCLUSIONS
• Dialysis in the past 4 months
• Hospitalization in the past 4 months
• Phlebotomy in the past 4 months
• Office Visits in the past 4 months
GENERAL EXCLUSIONS:
• Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
• Patients who have been in a skilled nursing facility in the last 3 months
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Patient Safety Project 2013-2014
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
ActiveHealth Management
Steward POC email
mvemireddy@activehealth.net
Importance
Equity
Feasibility
Scientific Acceptability
Risk Adjustment
Risk Adjustment
Use & Usability
Use
6.1.2 Current or Planned Use(s)
6.1.3 Current Use(s)
Public Comments